Registration of observational studies: Is it time?
暂无分享,去创建一个
Tony Tse | William R. Harlan | Rebecca J Williams | Deborah A. Zarin | D. Zarin | Tony Tse | Rebecca J. Williams | W. Harlan
[1] J. Avorn. In defense of pharmacoepidemiology--embracing the yin and yang of drug research. , 2007, The New England journal of medicine.
[2] K. Dickersin,et al. Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. , 1992, JAMA.
[3] Tony Tse,et al. Moving Toward Transparency of Clinical Trials , 2008, Science.
[4] Trish Groves,et al. Registration of observational studies , 2010, BMJ : British Medical Journal.
[5] P. Donnelly,et al. Replicating genotype–phenotype associations , 2007, Nature.
[6] B. Psaty,et al. Opportunities for enhancing the FDA guidance on pharmacovigilance. , 2008, JAMA.
[7] Ida Sim,et al. Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1) , 2005, BMJ : British Medical Journal.
[8] Sander Greenland,et al. Commentary: on 'quality in epidemiological research: should we be submitting papers before we have the results and submitting more hypothesis generating research?'. , 2007, International journal of epidemiology.
[9] Jan P Vandenbroucke,et al. Observational Research, Randomised Trials, and Two Views of Medical Science , 2008, PLoS medicine.
[10] S. Pocock,et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, Annals of Internal Medicine [serial online].
[11] S. Ebrahim. Cohorts, infants and children , 2004 .
[12] J. Vandenbroucke. What is the best evidence for determining harms of medical treatment? , 2006, Canadian Medical Association Journal.
[13] Z. Bankowski,et al. Council for International Organizations of Medical Sciences , 1991 .
[14] Susan Rose,et al. International Ethical Guidelines for Epidemiological Studies By the Council for International Organizations of Medical Sciences (CIOMS) , 2009 .
[15] P. Easterbrook,et al. Publication bias in clinical research , 1991, The Lancet.
[16] O. Kirk,et al. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration , 2008, The Lancet.
[17] Bernard C. K. Choi,et al. Vision for a global registry of anticipated public health studies. , 2007, American journal of public health.
[18] F. Rockhold,et al. Public disclosure of clinical research , 2009, The Lancet.